作者：
Jorien,Veldwijk [1]
;
Rachael Lynn,DiSantostefano [2]
;
Ellen,Janssen [3]
;
Gwenda,Simons [4]
;
Matthias,Englbrecht [4]
;
Karin,Schölin Bywall [5]
;
Christine,Radawski [6]
;
Karim,Raza [7]
;
Brett,Hauber [8]
;
Marie,Falahee [9]
作者单位：
School of Health Policy and Management, Erasmus University Rotterdam, P.O. Box 1738, 3000, Rotterdam, The Netherlands. veldwijk@eshpm.eur.nl.
[1]
Erasmus Choice Modelling Centre, Erasmus University Rotterdam, Rotterdam, The Netherlands. veldwijk@eshpm.eur.nl.
[2]
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. veldwijk@eshpm.eur.nl.
[3]
Janssen Research & Development, Titusville, NJ, USA.
[4]
Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
[5]
Freelance Healthcare Data Scientist, Greven, Germany.
[6]
Department of Internal Medicine and Institute for Clinical Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
[7]
Centre for Research Ethics & Bioethics, Uppsala University, Uppsala, Sweden.
[8]
Eli Lilly and Company, Indianapolis, IN, USA.
[9]
Department of Rheumatology, Sandwell and West Birmingham NHS Trust, Birmingham, UK.
[10]
MRC Versus Arthritis Centre for Musculoskeletal Ageing Research and Research into Inflammatory Arthritis Centre Versus Arthritis, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
[11]
Pfizer, Inc., New York, NY, USA.
[12]
The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington School or Pharmacy, Seattle, WA, USA.
[13]
DOI
10.1007/s40271-023-00643-w
PMID
37647010
发布时间
2023-10-15
换一批
换一批
